Fei‐Ran Gong

1.4k total citations
38 papers, 1.1k citations indexed

About

Fei‐Ran Gong is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Fei‐Ran Gong has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cancer Research, 19 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in Fei‐Ran Gong's work include Beetle Biology and Toxicology Studies (11 papers), Inflammatory Biomarkers in Disease Prognosis (10 papers) and Cancer, Lipids, and Metabolism (4 papers). Fei‐Ran Gong is often cited by papers focused on Beetle Biology and Toxicology Studies (11 papers), Inflammatory Biomarkers in Disease Prognosis (10 papers) and Cancer, Lipids, and Metabolism (4 papers). Fei‐Ran Gong collaborates with scholars based in China and United States. Fei‐Ran Gong's co-authors include Min Tao, Mengyao Wu, Qiaoming Zhi, Meng Shen, Min Tao, Mengdan Xu, Lian Lian, Wei Li, Liu‐Mei Shou and Chong Zhou and has published in prestigious journals such as Nucleic Acids Research, Blood and Scientific Reports.

In The Last Decade

Fei‐Ran Gong

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei‐Ran Gong China 22 486 422 375 145 110 38 1.1k
Jana Nekvindová Czechia 20 846 1.7× 193 0.5× 672 1.8× 158 1.1× 45 0.4× 48 1.4k
Jingjing Zhang China 21 893 1.8× 384 0.9× 565 1.5× 107 0.7× 325 3.0× 62 1.4k
Cheng‐Yu Wu China 15 494 1.0× 270 0.6× 100 0.3× 234 1.6× 165 1.5× 35 899
Maureen A. Harrington United States 21 754 1.6× 194 0.5× 276 0.7× 91 0.6× 319 2.9× 45 1.2k
Haisheng Zhou China 15 522 1.1× 165 0.4× 199 0.5× 150 1.0× 198 1.8× 31 964
Shuming Sun China 21 566 1.2× 120 0.3× 145 0.4× 61 0.4× 144 1.3× 51 959
Gaetano Leto Italy 22 524 1.1× 403 1.0× 386 1.0× 120 0.8× 57 0.5× 59 1.3k
Xiaomei Zhang China 20 660 1.4× 190 0.5× 360 1.0× 92 0.6× 146 1.3× 38 1.0k
Norma Llansa United States 13 534 1.1× 285 0.7× 262 0.7× 90 0.6× 265 2.4× 15 1.1k

Countries citing papers authored by Fei‐Ran Gong

Since Specialization
Citations

This map shows the geographic impact of Fei‐Ran Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei‐Ran Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei‐Ran Gong more than expected).

Fields of papers citing papers by Fei‐Ran Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei‐Ran Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei‐Ran Gong. The network helps show where Fei‐Ran Gong may publish in the future.

Co-authorship network of co-authors of Fei‐Ran Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Fei‐Ran Gong. A scholar is included among the top collaborators of Fei‐Ran Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei‐Ran Gong. Fei‐Ran Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shen, Meng, Mengyao Wu, Qiaoming Zhi, et al.. (2021). Author Correction: Cantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA. Scientific Reports. 11(1). 5063–5063. 1 indexed citations
3.
Wu, Jing, Fei‐Ran Gong, Mengyao Wu, et al.. (2019). Prognostic evaluation of resectable colorectal cancer using platelet‑associated indicators. Oncology Letters. 18(1). 571–580. 27 indexed citations
4.
Wang, Yi, Mengdan Xu, Fei‐Ran Gong, et al.. (2018). The values of applying classification and counts of white blood cells to the prognostic evaluation of resectable gastric cancers. BMC Gastroenterology. 18(1). 99–99. 10 indexed citations
5.
Xu, Mengdan, Lu Liu, Mengyao Wu, et al.. (2018). The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic cancer. Oncogenesis. 7(11). 94–94. 28 indexed citations
6.
Wu, Xiao Yu, Mengyao Wu, Min Jiang, et al.. (2017). TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells. Cancer Cell International. 17(1). 13–13. 61 indexed citations
7.
Shen, Xiaoming, Youyou Xia, Lian Lian, et al.. (2016). Mean platelet volume provides beneficial diagnostic and prognostic information for patients with resectable gastric cancer. Oncology Letters. 12(4). 2501–2506. 43 indexed citations
8.
Li, Wei, Lijun Dai, Ziling Zhu, et al.. (2015). Comparison of SPE, IFE, and FLC in Monitoring Patients with Multiple Myeloma After Autologous Stem Cell Transplantation. Cell Biochemistry and Biophysics. 73(3). 643–647. 4 indexed citations
9.
Lian, Lian, Youyou Xia, Chong Zhou, et al.. (2015). Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer. Cancer Biomarkers. 15(6). 899–907. 80 indexed citations
10.
Wang, Wenjie, Mengyao Wu, Meng Shen, et al.. (2015). Cantharidin and norcantharidin impair stemness of pancreatic cancer cells by repressing the β-catenin pathway and strengthen the cytotoxicity of gemcitabine and erlotinib. International Journal of Oncology. 47(5). 1912–1922. 35 indexed citations
11.
Li, Wei, Rongrui Liang, Chong Zhou, et al.. (2015). The association between expressions of Ras and CD68 in the angiogenesis of breast cancers. Cancer Cell International. 15(1). 17–17. 15 indexed citations
12.
Lian, Lian, Youyou Xia, Chong Zhou, et al.. (2015). Mean platelet volume predicts chemotherapy response and prognosis in patients with unresectable gastric cancer. Oncology Letters. 10(6). 3419–3424. 24 indexed citations
13.
14.
Li, Wei, Mengyao Wu, Rongrui Liang, et al.. (2015). FH535 inhibited metastasis and growth of pancreatic cancer cells. OncoTargets and Therapy. 8. 1651–1651. 14 indexed citations
15.
Gong, Fei‐Ran, Mengyao Wu, Meng Shen, et al.. (2015). PP2A inhibitors arrest G2/M transition through JNK/Sp1-dependent down-regulation of CDK1 and autophagy-dependent up-regulation of p21. Oncotarget. 6(21). 18469–18483. 35 indexed citations
16.
Shen, Meng, Weiming Duan, Mengyao Wu, et al.. (2015). Participation of autophagy in the cytotoxicity against breast cancer cells by cisplatin. Oncology Reports. 34(1). 359–367. 30 indexed citations
17.
Shou, Liu‐Mei, Qiongyan Zhang, Wei Li, et al.. (2013). Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin. Oncology Reports. 30(3). 1059–1066. 54 indexed citations
18.
19.
Gong, Fei‐Ran, Luan Sun, & Yujie Sun. (2010). A novel SATB1 binding site in the BCL2 promoter region possesses transcriptional regulatory function. Journal of Biomedical Research. 24(6). 452–459. 5 indexed citations
20.
Yang, Nan, Fei‐Ran Gong, Luan Sun, et al.. (2010). Poly (ADP‐ribose) polymerase‐1 binds to BCL2 major breakpoint region and regulates BCL2 expression. Journal of Cellular Biochemistry. 110(5). 1208–1218. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jana Nekvindová Breakdown of academic impact, for papers by Jingjing Zhang Breakdown of academic impact, for papers by Cheng‐Yu Wu Breakdown of academic impact, for papers by Maureen A. Harrington Breakdown of academic impact, for papers by Haisheng Zhou Breakdown of academic impact, for papers by Shuming Sun Breakdown of academic impact, for papers by Gaetano Leto Breakdown of academic impact, for papers by Xiaomei Zhang Breakdown of academic impact, for papers by Norma Llansa
Rankless by CCL
2026